1. Home
  2. BCAB vs HSON Comparison

BCAB vs HSON Comparison

Compare BCAB & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • HSON
  • Stock Information
  • Founded
  • BCAB 2007
  • HSON 1999
  • Country
  • BCAB United States
  • HSON United States
  • Employees
  • BCAB N/A
  • HSON N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • HSON Professional Services
  • Sector
  • BCAB Health Care
  • HSON Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • HSON Nasdaq
  • Market Cap
  • BCAB 22.3M
  • HSON 26.1M
  • IPO Year
  • BCAB 2020
  • HSON N/A
  • Fundamental
  • Price
  • BCAB $0.41
  • HSON $9.00
  • Analyst Decision
  • BCAB Buy
  • HSON
  • Analyst Count
  • BCAB 2
  • HSON 0
  • Target Price
  • BCAB $1.00
  • HSON N/A
  • AVG Volume (30 Days)
  • BCAB 421.1K
  • HSON 5.4K
  • Earning Date
  • BCAB 05-06-2025
  • HSON 05-13-2025
  • Dividend Yield
  • BCAB N/A
  • HSON N/A
  • EPS Growth
  • BCAB N/A
  • HSON N/A
  • EPS
  • BCAB N/A
  • HSON N/A
  • Revenue
  • BCAB $11,000,000.00
  • HSON $138,031,000.00
  • Revenue This Year
  • BCAB N/A
  • HSON $0.80
  • Revenue Next Year
  • BCAB N/A
  • HSON $8.09
  • P/E Ratio
  • BCAB N/A
  • HSON N/A
  • Revenue Growth
  • BCAB N/A
  • HSON N/A
  • 52 Week Low
  • BCAB $0.24
  • HSON $8.49
  • 52 Week High
  • BCAB $2.53
  • HSON $19.70
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 50.31
  • HSON 39.43
  • Support Level
  • BCAB $0.37
  • HSON $8.49
  • Resistance Level
  • BCAB $0.42
  • HSON $9.19
  • Average True Range (ATR)
  • BCAB 0.04
  • HSON 0.53
  • MACD
  • BCAB -0.01
  • HSON -0.11
  • Stochastic Oscillator
  • BCAB 35.88
  • HSON 24.17

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: